Apricus BioSciences IR Series: Featuring Dr. Bassam Damaj
Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Chairman, President and Chief Executive Officer, Dr. Bassam Damaj, was interviewed recently by the CEOLIVE financial network (http://ceolive.tv/). During the interview, Dr. Damaj reported on plans for the Company's pipeline, including the proposed commercialization in Canada and Europeof Vitaros®, a topical treatment for erectile dysfunction.
#
